NEW YORK (GenomeWeb News) — HistoRx today said it has raised $6 million in a round of Series B private-equity financing.
The company, based in New Haven, Conn., said it will use the cash to develop and commercialize its tissue-based diagnostics products, which are based on its AQUA biomarker-analysis platform.
“These funds provide the resources necessary to move our product portfolio of diagnostic tests through later-stage development, FDA approval, and commercialization," HistoRx CEO Rana Gupta said in a statement.
The round was led by current investor Brook Venture Partners. Other backers included current investor Navigator Technology Ventures and new investors the Roche Venture Fund, Commons Capital, and Maven Capital.